Leaders and experts from the stem cell and regenerative medicine industry once again came to London at the end of May for the 7th Annual World Stem Cells & Regenerative Medicine Congress.
The congress has grown in conjunction with the industry and as more companies are announcing regulatory success for their stem cell-based therapies (and with numerous cell therapies in late stage development) the industry at large is gathering critical mass to significantly influence healthcare. A standout ethos running through the congress was the undoubted support offered from one company to another.Individual successes are proud moments for a relatively young industry that offers tremendous potential but continues to require support and success stories to overcome conservative investors, media and public alike.
The World Stem Cells & Regenerative Medicine Congress 2012 welcomed the largest gathering of attendees to date to experience the industry shaping announcements, debates and networking and collaboration opportunities that will help drive this industry forward.
For a comprehensive summary and breakdown of this years congress, feel free to download the post event report here that summarises the major themes of the meeting, delegation breakdown and importantly the innovative steps being taken to evolve the congress experience in 2013. It is essential the World Stem Cells & Regenerative Medicine Congress 2013 continues to grow with this pioneering field, and continue to assist the industry collective to tackle their development challenges.
Were you at the event?Â We would love to hear your feedback-Â comment below